Brief: Coherus Announces FDA Approval Of UDENYCA ONBODY

Coherus Oncology

26/12/2023 21:05

Dec 27 (Reuters) - Coherus BioSciences Inc  CHRS.O :
    * COHERUS ANNOUNCES FDA APPROVAL OF UDENYCA ONBODY™, A NOVEL
AND
PROPRIETARY STATE-OF-THE-ART DELIVERY SYSTEM FOR
PEGFILGRASTIM-CBQV
    * COHERUS ANNOUNCES FDA APPROVAL OF UDENYCA ONBODY™, A NOVEL
AND
PROPRIETARY STATE-OF-THE-ART DELIVERY SYSTEM FOR
PEGFILGRASTIM-CBQV
    * COHERUS BIOSCIENCES INC - COMMERCIAL AVAILABILITY OF
UDENYCA
ONBODY IS PLANNED FOR Q1 OF 202

Source text for Eikon:  ID:nGNX4HHvN9 
Further company coverage:  CHRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))